Key Metrics
Q4
Neurology (clinical)
SJR
- Q4 Neurology (clinical)
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
3 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Indexed in the following public directories
-
Scopus -
DOAJ
Topics Covered
- Migraine
- Functional connectivity
- Cluster headache
- New daily persistent headache
- Episodic migraine
- Sumatriptan
Journal Specifications
| Overview | |
| Publisher | SAGE |
| Language | English |
| Article Processing Charges | USD 1500 |
| Publication Time | 9 |
| Editorial Review Process | Blind peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | International Headache Society |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Waiver Policy | Visit website |
| Publication Time | 9 |
| Article Processing Charges | USD 1500 |
| Editorial Review Detail | |
| Editorial Team | Visit website |
| Review Process | Blind peer review |
| Review Url | Visit website |
| Information for authors | |
| Author instructions | Visit website |
| License type | CC BY-NC |
| OA statement | Visit website |
Planning to publish in Cephalalgia Reports ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Extended regular use of kinetic oscillation stimulation (KOS) in refractory chronic migraine: case report of a first, single-subject experience
- 1 Jan 24
- Cephalalgia Reports
-
Full paper
Rimegepant as an acute treatment in a refractory migraine patient non-responder to two anti-CGRP monoclonal antibodies and triptans: Case report and pharmacological considerations
- 1 Jan 24
- Cephalalgia Reports
-
Full paper
Tolerability of calcitonin gene-related peptide monoclonal antibodies and other monoclonal antibodies in adults with concurrent migraine and other medical conditions
- 1 Jan 24
- Cephalalgia Reports
-
Full paper
Real-world effectiveness of add-on fremanezumab in patients receiving onabotulinumtoxinA for the prevention of chronic migraine in a US tertiary headache center: A retrospective chart review study
- 1 Jan 24
- Cephalalgia Reports
-
Full paper
A century of bruxism research in top-ranking medical journals
- 1 Jan 24
- Cephalalgia Reports
-
Full paper
Protocol of a cross-sectional, multicentre and multidisciplinary study describing phenotype and burden of a midfacial segment pain
- 1 Jan 24
- Cephalalgia Reports
Scite analysis
Powered by scite_
148 articles received 543 citations see all
- 36 Supporting
- 491 Mentioning
- 4 Contrasting
Editorial notices
- 0 Retractions
- 0 Withdrawals
- 6 Corrections
- 0 Errata
- 0 Expression of Concern
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
44%
4 to 6 months
56%
7 to 9 months
0%
Above 9 months
0%
Did you find this useful?
Thank you for your feedback.
